ArticleJournal for immunotherapy of cancer2026

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors.

John L Villano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.